US approves first drug for severe form of fatty liver disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
Mar 15, 2024
0
3
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
Mar 15, 2024
0
3
Researchers at Weill Cornell Medicine have discovered a protein called SEL1L that plays a critical role in clearing collagen from tissue, and that may be a therapeutic target to help prevent fibrosis, scar tissue that interferes ...
Mar 26, 2024
0
16
Cutting-edge bioluminescence technology pioneered at The University of Western Australia has been used to uncover a potential game-changer in immunotherapy.
Mar 20, 2024
0
42
Over the past decade, regulatory agencies such as the Federal Drug Administration (FDA) in the United States and the and the European Medicines Agency (EMA) in the European Union have put programs in place to get new drugs ...
Mar 13, 2024
0
0
ASPIRE to Innovate Postdoctoral Fellow Catherine Leasure is the co-author of a comment article published this month in Nature Reviews Bioengineering addressing the pressing obstacle faced by modern drug development: worryingly ...
Mar 4, 2024
0
27
New treatments for depression are needed that act rapidly and also have sustained effects. Ketamine accomplishes this, but toxic side effects limit its long-term use. Scientists haven't understood how ketamine was able to ...
Feb 29, 2024
0
1